Alterations in Pulmonary Function Following Respiratory Viral Infection
Alterations in Pulmonary Function Following Respiratory Viral Infection
- Research Article
89
- 10.1016/j.jaci.2010.04.002
- May 31, 2010
- The Journal of Allergy and Clinical Immunology
Viral respiratory tract infections and asthma: The course ahead
- Research Article
178
- 10.1378/chest.130.4.1203
- Oct 1, 2006
- Chest
How Viral Infections Cause Exacerbation of Airway Diseases
- Research Article
37
- 10.1016/j.celrep.2021.109401
- Jul 1, 2021
- Cell Reports
Respiratory syncytial virus (RSV) is a major cause of serious acute lower respiratory tract infection in infants and the elderly. The lack of a licensed RSV vaccine calls for the development of vaccines with other targets and vaccination strategies. Here, we construct a recombinant protein, designated P-KFD1, comprising RSV phosphoprotein (P) and the E.-coli-K12-strain-derived flagellin variant KFD1. Intranasal immunization with P-KFD1 inhibits RSV replication in the upper and lower respiratory tract and protects mice against lung disease without vaccine-enhanced disease (VED). The P-specific CD4+ Tcells provoked by P-KFD1 intranasal (i.n.) immunization either reside in or migrate to the respiratory tract and mediate protection against RSV infection. Single-cell RNA sequencing (scRNA-seq) and carboxyfluorescein succinimidyl ester (CFSE)-labeled cell transfer further characterize the Th1 and Th17 responses induced by P-KFD1. Finally, we find that anti-viral protection depends on either interferon-γ (IFN-γ) or interleukin-17A (IL-17A). Collectively, P-KFD1 is a promising safe and effective mucosal vaccine candidate for the prevention of RSV infection.
- Research Article
4
- 10.1016/s0091-6749(98)70236-2
- Feb 1, 1998
- Journal of Allergy and Clinical Immunology
Current research and future needs in allergic rhinitis and asthma
- Research Article
20
- 10.1111/j.1600-6135.2004.00734.x
- Oct 1, 2004
- American Journal of Transplantation
Community-acquired respiratory viruses
- Research Article
117
- 10.1016/j.bbmt.2009.12.534
- Jan 6, 2010
- Biology of Blood and Marrow Transplantation
Strong Association between Respiratory Viral Infection Early after Hematopoietic Stem Cell Transplantation and the Development of Life-Threatening Acute and Chronic Alloimmune Lung Syndromes
- Research Article
103
- 10.1016/j.rmed.2007.07.015
- Sep 5, 2007
- Respiratory Medicine
A community-based, time-matched, case-control study of respiratory viruses and exacerbations of COPD
- Research Article
399
- 10.1016/j.jaci.2006.03.003
- May 1, 2006
- Journal of Allergy and Clinical Immunology
The many faces of the hygiene hypothesis
- Research Article
- 10.1111/j.1365-2222.2006.02583_7.x
- Oct 1, 2006
- Clinical & Experimental Allergy
Infections, Immunity & their Effects on Asthma
- Front Matter
49
- 10.1016/j.jaci.2006.06.023
- Sep 1, 2006
- Journal of Allergy and Clinical Immunology
Rhinoviruses in the pathogenesis of asthma: The bronchial epithelium as a major disease target
- Front Matter
4
- 10.1016/j.jpeds.2022.10.001
- Oct 11, 2022
- The Journal of pediatrics
Epidemiologic Changes Caused by the Preventive Measures for the Coronavirus Disease 2019 Pandemic: An Additional Challenge for Pediatricians
- Research Article
57
- 10.1016/j.metabol.2020.154276
- May 26, 2020
- Metabolism: clinical and experimental
Commentary: Myths and facts on vitamin D amidst the COVID-19 pandemic
- Research Article
55
- 10.1016/j.jaci.2015.11.016
- Jan 21, 2016
- Journal of Allergy and Clinical Immunology
Human nasal epithelial cells derived from multiple subjects exhibit differential responses to H3N2 influenza virus infection in vitro
- Discussion
48
- 10.1016/j.jaci.2004.08.038
- Dec 1, 2004
- Journal of Allergy and Clinical Immunology
Transient postviral vocal cord dysfunction
- Research Article
56
- 10.1038/mt.2008.81
- Jun 1, 2008
- Molecular therapy : the journal of the American Society of Gene Therapy
Inhibition of Respiratory Syncytial Virus Infections With Morpholino Oligomers in Cell Cultures and in Mice